Skip to content
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us
CatSci CatSci
  • Home
  • Who we are
  • What we do
    • Small Molecule
      Early Development
    • Small Molecule
      Late Development
    • Route Scouting and Selection
    • High Potency APIs
    • Solid State & Preformulation
    • Analytical Science
    • Separation Science
    • Oligonucleotides
    • Peptides
  • SmartPath
  • Digital Walkthrough
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us

Biocatalysis

Categories
BlogBook ChaptersCase StudiesPapersPatentsPresentationsThought LeadersWebinarsWhitepapers
Tags
Analytical Chemistry Analytical Science Artificial Intelligence (AI) Biocatalysis Catalysis CatSci Paper CatSci Patent Chemical Development Complex Synthetic Medicines Design of Experiments Digital Drug Development Experimental Design Green Chemistry Industry insights Innovation Machine Learning (ML) Material Science Medium Throughput Experimentation Oligonucleotides Peptides Principal Component Analysis Process R&D PROTACs QbD Route Scouting and Selection Scale-up Scavenging Solvents Sustainability Technology transfer Work-up
CatSci Enjoy CatFest – A Summer Celebration of CatSci

Last Thursday, the CatSci team enjoyed a summer celebration, CatFest. This was a CatSci-style festival to celebrate the hard work of our fantastic team.

Sep 23rd 2022
Chemistry Today: Panel Discussion on Catalysis

CatSci's Senior Scientist, Dr Alice Dunbabin, participated in the latest Chemistry Today panel discussion on Catalysis.

2022 By Alice Dunbabin
The Medicine Maker: Are You a Bio-Catalytic Converter?

Speed and efficiency are everything in pharmaceutical synthesis – and that’s why biocatalysis is an increasingly attractive option.

2021 By Alice Dunbabin
Ketone Reductase Biocatalysis in the Synthesis of Chiral Intermediates Toward Generic Active...

Org. Process Res. Dev. 2020, 24, 6, 1131–1140

2020 By Dan A. SmithJoanne B. SampsonSiân M. Forsyth, et al.
Pharmaceutical Technology: Updating Manufacturing Processes to Improve Sustainability

Earlier this year, CatSci’s team spoke with Pharmaceutical Technology to discuss what makes our novel biocatalytic manufacturing process unique.

2019 By CatSci team
Biocatalysis Whitepaper – Lipases

Development of a DKR for the manufacture of (S)-Flurbiprofen

2018 By CatSci team
Opinion Piece – Why Biocatalysis?

Why Biocatalysis?

2018 By CatSci team
Characterization of the first naturally thermostable terpene synthases and development of st...

The FEBS Journal 284 (2017) 1700–1711

2017 By Marc Hutchby, et al.
Process for the preparation of a stereospecific form of flurbiprofen, or a pharmaceutically ...

WO2016110708

2016 By CatSci team, et al.

Helpful Links

  • Contact Us
  • Careers
  • Safety, Health and Environment
  • Privacy Policy
  • CatSci Corporate and Social Responsibility (CSR) Policy
  • Sustainability Report 2024

What we do

  • Small Molecule Late Development
  • Small Molecule Early Development
  • Route Scouting and Selection
  • Analytical Science
  • High Potency APIs
  • Solid State and Preformulation
  • Oligonucleotides

Who we are

CatSci Ltd are an award-winning innovation partner for medicines development who are committed to creating tailored solutions from candidate selection through product launch and beyond. We break down the silos in small molecules, TACS, glues and oligonucleotides CMC development to accelerate the delivery of life-changing medicines to patients in need. 

© 2025 CatSci Ltd. All rights reserved.
Registered in England & Wales.
Company No. 07466141.